Tyrosine-protein kinase Fyn — Drug Target

All drugs that target Tyrosine-protein kinase Fyn — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Anthracycline Topoisomerase Inhibitor · sodium aurothiomalate · Aromatic Amino Acid [EPC]

Marketed (3)

• Ellence · Pfizer · Anthracycline Topoisomerase Inhibitor · Oncology
  Ellence works by intercalating DNA and inhibiting topoisomerase II, disrupting cancer cell growth.
• Aurolate · sodium aurothiomalate · Immunology
• Inbrija · Merz · Aromatic Amino Acid [EPC] · Neuroscience
  Levodopa works by crossing the blood-brain barrier and being converted into dopamine, a neurotransmitter that helps regulate movement and coordination.